TP53 and mesothelioma: By GSEA, there was a significant TEAD/YAP conserved signature enrichment in TNBCs with p53 DNA contact mutations compared to those with p53 conformational mutations (Supplementary Fig. 15a), as well as in mesothelioma patients with Hippo pathway mutations (Supplementary Fig. 15b).